Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how the fight to own a future coronavirus vaccine is revealing the boundaries of interna ... Show More
Today
The Bond Market Is Flipping Out. Here’s Why You Should Care.
For the past few months, you’ve probably been hearing about the turbulence in the bond market.Today, Ben Casselman, the chief economics correspondent for The New York Times, explains what has been happening, and why it matters.Guest: Ben Casselman, the chief economics corresponde ... Show More
28m 28s
Yesterday
The A.I. Researcher Whose Rebellion Is Changing Everything
In recent days, Jacob Coxon, a researcher at the artificial intelligence company Anthropic, quit his job and posted warnings about the risks of the technology. That kicked off a crisis that culminated in a call by prominent leaders of the industry to slow down A.I. development.He ... Show More
34m 13s
Sep 13
The Good, the Bad and the Good-Bad (Movie)
When it comes to movies we love, there are the artistic masterpieces and there are the foot-stomping crowd pleasers. But there’s another particular kind of beloved movie, the one that makes our friends groan, but that we rewatch incessantly; the one that we can quote line for lin ... Show More
37m 36s
May 2020
The race for a vaccine, the story behind EBITDAC, BoE’s Bailey
<p>The hunt for a coronavirus vaccine is central to global efforts to restart economies. The FT’s US coronavirus correspondent, David Crow, explains how nationalism could slow the fight against the pandemic. Plus, some companies are presenting a new customised metric they are cal ... Show More
9m 45s